![Peter A. Zorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter A. Zorn
Präsident bei
Genevant Sciences, Inc.
Profil
Peter A. Zorn currently works at Genevant Sciences Corp., as Chief Operating Officer from 2019, Genevant Sciences, Inc., as President & Chief Legal Officer from 2020, and Womble Bond Dickinson (US) LLP.
Mr. Zorn also formerly worked at Targacept, Inc., as Secretary, SVP-Legal Affairs & General Counsel from 2010 to 2013, Roche Innovation Center Copenhagen A, as General Counsel & Vice President-Communications, and Albireo Pharma, Inc., as Secretary & General Counsel from 2015 to 2018.
Mr. Zorn received his undergraduate degree from Harvard University and graduate degree from The University of North Carolina at Charlotte.
Aktive Positionen von Peter A. Zorn
| Unternehmen | Position | Beginn |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Geschäftsführer | 07.01.2019 |
Genevant Sciences, Inc.
 Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | Präsident | 01.07.2020 |
Ehemalige bekannte Positionen von Peter A. Zorn
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | General Counsel | 01.04.2018 |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | General Counsel | 30.09.2013 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Public Communications Contact | - |
Ausbildung von Peter A. Zorn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Genevant Sciences, Inc.
Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | Health Technology |
